Sutton D - Search Results

1

Development of beta-lapachone prodrugs for therapy against human cancer cells with elevated NAD(P)H:quinone oxidoreductase 1 levels.

Reinicke KE, Bey EA, Bentle MS, Pink JJ, Ingalls ST, Hoppel CL, Misico RI, Arzac GM, Burton G, Bornmann WG, Sutton D, Gao J, Boothman DA. Reinicke KE, et al. Among authors: sutton d. Clin Cancer Res. 2005 Apr 15;11(8):3055-64. doi: 10.1158/1078-0432.CCR-04-2185. Clin Cancer Res. 2005. PMID: 15837761

2

Beta-lapachone-containing PEG-PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells.

Blanco E, Bey EA, Dong Y, Weinberg BD, Sutton DM, Boothman DA, Gao J. Blanco E, et al. Among authors: sutton dm. J Control Release. 2007 Oct 8;122(3):365-74. doi: 10.1016/j.jconrel.2007.04.014. Epub 2007 Apr 29. J Control Release. 2007. PMID: 17574288 Free PMC article.

3

Efficient suppression of secretory clusterin levels by polymer-siRNA nanocomplexes enhances ionizing radiation lethality in human MCF-7 breast cancer cells in vitro.

Sutton D, Kim S, Shuai X, Leskov K, Marques JT, Williams BR, Boothman DA, Gao J. Sutton D, et al. Int J Nanomedicine. 2006;1(2):155-62. doi: 10.2147/nano.2006.1.2.155. Int J Nanomedicine. 2006. PMID: 17722531 Free PMC article.

4

Combined modeling and experimental approach for the development of dual-release polymer millirods.

Qian F, Saidel GM, Sutton DM, Exner A, Gao J. Qian F, et al. J Control Release. 2002 Oct 30;83(3):427-35. doi: 10.1016/s0168-3659(02)00217-1. J Control Release. 2002. PMID: 12387950

5

Doxorubicin and beta-lapachone release and interaction with micellar core materials: experiment and modeling.

Sutton D, Wang S, Nasongkla N, Gao J, Dormidontova EE. Sutton D, et al. Exp Biol Med (Maywood). 2007 Sep;232(8):1090-9. doi: 10.3181/0702-RM-31. Exp Biol Med (Maywood). 2007. PMID: 17720955

6

Functionalized micellar systems for cancer targeted drug delivery.

Sutton D, Nasongkla N, Blanco E, Gao J. Sutton D, et al. Pharm Res. 2007 Jun;24(6):1029-46. doi: 10.1007/s11095-006-9223-y. Epub 2007 Mar 24. Pharm Res. 2007. PMID: 17385025 Review.

7

Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel, phase 3 superiority trial.

TREATT Trial Investigators. TREATT Trial Investigators. Lancet Haematol. 2024 Dec 3:S2352-3026(24)00317-X. doi: 10.1016/S2352-3026(24)00317-X. Online ahead of print. Lancet Haematol. 2024. PMID: 39642900

8

Minimally invasive technique to facilitate ultrasound-guided removal of migrating foreign bodies: eight cases (2022).

Brincin C, Anderson OJ, Field EJ, Howes C, Reeve E, Sutton D. Brincin C, et al. Among authors: sutton d. J Small Anim Pract. 2024 Nov 24. doi: 10.1111/jsap.13808. Online ahead of print. J Small Anim Pract. 2024. PMID: 39581947

9

A strategy for achieving optimisation of radiological protection in digital radiology proposed by ICRP.

Martin CJ, Kortesniemi MK, Sutton DG, Applegate K, Vassileva J. Martin CJ, et al. Among authors: sutton dg. J Radiol Prot. 2024 Nov 18;44(4). doi: 10.1088/1361-6498/ad60d1. J Radiol Prot. 2024. PMID: 39555658

10

Low doses of ionising radiation: definitions and contexts.

Harrison JD, McCready-Shea S, Hill MA, Smith GM, Sutton DG. Harrison JD, et al. Among authors: sutton dg. J Radiol Prot. 2024 Oct 7. doi: 10.1088/1361-6498/ad83dd. Online ahead of print. J Radiol Prot. 2024. PMID: 39374619

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,103 results

Search Page

Filters